Busulfan and melphalan as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma-Reference-Cited by-同舟云学术

Busulfan and melphalan as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma

Published:1995-10 Issue:2 Volume:91 Page:380-386
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Alegre A.,Lamana M.,Arranz R.,Fernández-Villalta M. J.,Tomás J. F.,Figuera A.,Cámara R.,Steegman J. L.,Casado F.,Requena M. J.,Planas J. L.,Vazquez L.,Granda A.,Fernández-Rañada J. M.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.1995.tb05307.x/fullpdf

Reference36 articles.

1. A. Alegre, M.J. Fernandez-Villalta, M. Lamana, T. Merino, M.J. Requena, L. Hernandez, R. Arranz, and J.M. Fernandez-Raada (1993 ) Experience with large-volume leucapheresis (LVL) to improve peripheral blood mononuclear stem cell (PBMNSC) collection. (Abstract).Proceedings of the International Symposium on Peripheral Blood Stem Cell Autografts, Bordeaux, France, 156a .

2. Intensive combined therapy for previously untreated aggressive myeloma

3. Plasma cell myeloma--new biological insights and advances in therapy

4. High-dose melphalan with autologous bone marrow transplantation for multiple myeloma

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose-intensified bendamustine and melphalan (BenMel) conditioning before second autologous transplantation in myeloma patients;Hematological Oncology;2018-09-11

2. A phase II, single-arm, prospective study of bendamustine plus melphalan conditioning for second autologous stem cell transplantation in de novo multiple myeloma patients through a tandem transplant strategy;Bone Marrow Transplantation;2016-04-18

3. High-dose Preparatory Regimens;Thomas’ Hematopoietic Cell Transplantation;2016-01-01

4. Conditioning regimens for hematopoietic cell transplantation: one size does not fit all;Blood;2014-07-17

5. Efficacy and Safety of Busulfan-Based Conditioning Regimens for Multiple Myeloma;The Oncologist;2013-04-29